ACHN
Achillion Pharmaceuticals
ACHN
ACHN
Delisted
ACHN was delisted on the 27th of January, 2020.
122 hedge funds and large institutions have $402M invested in Achillion Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 43 increasing their positions, 32 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
7% more funds holding
Funds holding: 114 → 122 (+8)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
122
Holding in Top 10
1
Calls
$1.94M
Puts
$854K
Top Buyers
| 1 | +$7.2M | |
| 2 | +$3.15M | |
| 3 | +$3.04M | |
| 4 |
PVI
Pura Vida Investments
New York
|
+$2.04M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$1.29M |
Top Sellers
| 1 | -$4.22M | |
| 2 | -$3.89M | |
| 3 | -$3.75M | |
| 4 |
D.E. Shaw & Co
New York
|
-$1.97M |
| 5 |
Man Group
London,
United Kingdom
|
-$1.73M |